These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Indomethacin and atrial natriuretic peptide in Bartter's syndrome. Gordon RD, Tunny TJ, Klemm SA. N Engl J Med; 1986 Aug 14; 315(7):459. PubMed ID: 2942775 [No Abstract] [Full Text] [Related]
24. [Compensatory growth in a boy with Bartter's syndrome treated with indomethacin]. Lejarraga H, Schnitzler EJ, Di Candia A, Ferraris JR. Bol Med Hosp Infant Mex; 1986 Mar 14; 43(3):151-6. PubMed ID: 3707692 [No Abstract] [Full Text] [Related]
26. Effect of indomethacin in a patient with Bartter's syndrome: evidence against a primary role of prostaglandin in this disorder. Etzioni A, Chaimovitz C, Levi Y, Benderli A, Better OS. Pediatr Res; 1980 Dec 14; 14(12):1395-7. PubMed ID: 7010289 [Abstract] [Full Text] [Related]
27. Transient gall bladder dilatation associated with hypokalaemia in a patient with Bartter syndrome. Goren A, Drachman R, Hadas-Halperin I, Drukker A. Eur J Pediatr; 1989 Nov 14; 149(2):88-9. PubMed ID: 2686998 [Abstract] [Full Text] [Related]
28. [Tetany as a sole manifestation in a patient with Bartter's syndrome and a successful treatment with indomethacin]. Fujihara K, Miyoshi T, Yamaguchi Y, Araki T, Tanaka K. Rinsho Shinkeigaku; 1990 May 14; 30(5):529-32. PubMed ID: 2401113 [Abstract] [Full Text] [Related]
29. Hypercalciuria with Bartter syndrome: evidence for an abnormality of vitamin D metabolism. Restrepo de Rovetto C, Welch TR, Hug G, Clark KE, Bergstrom W. J Pediatr; 1989 Sep 14; 115(3):397-404. PubMed ID: 2671327 [Abstract] [Full Text] [Related]
31. [Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis]. Favre L, Glasson P, Flory ED, Dray F, Vallotton MB. Schweiz Med Wochenschr; 1979 Feb 03; 109(5):142-7. PubMed ID: 441720 [Abstract] [Full Text] [Related]
32. Idiopathic hypercalciuria associated with hyperreninemia and high urinary prostaglandin E. Houser M, Zimmerman B, Davidman M, Smith C, Sinaiko A, Fish A. Kidney Int; 1984 Aug 03; 26(2):176-82. PubMed ID: 6389955 [Abstract] [Full Text] [Related]
33. The role of prostaglandins in Bartter's syndrome. Winterborn MH, Hewitt GJ, Mitchell MD. Int J Pediatr Nephrol; 1984 Mar 03; 5(1):31-8. PubMed ID: 6370882 [Abstract] [Full Text] [Related]
34. [The neonatal form of Bartter's syndrome: current findings in etiology and physiopathology]. Proesmans WC. Verh K Acad Geneeskd Belg; 1992 Mar 03; 54(3):253-93. PubMed ID: 1413986 [Abstract] [Full Text] [Related]
36. [Aspirin and indomethacin therapy in 2 familial cases of Bartter's disease. Follow-up for growth and endocrine pattern]. Villa MP, Zappulla F, Salardi S, Balsamo A, Vecchi F, Pirazzoli P, Bernardi F, Cicognani A, Cacciari E. Minerva Pediatr; 1980 Nov 15; 32(21):1259-68. PubMed ID: 7219366 [No Abstract] [Full Text] [Related]
37. Correction of increased prostacyclin production in Bartter's syndrome by indomethacin. Güllner HG, Cerletti C, Bartter FC, Gill JR, Smith JB. Trans Assoc Am Physicians; 1980 Nov 15; 93():130-40. PubMed ID: 7018063 [No Abstract] [Full Text] [Related]
38. Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide. Nüsing RM, Reinalter SC, Peters M, Kömhoff M, Seyberth HW. Clin Pharmacol Ther; 2001 Oct 15; 70(4):384-90. PubMed ID: 11673754 [Abstract] [Full Text] [Related]
39. [The role of prostaglandins in the pathogenesis of Bartter's syndrome]. Radó J, Simatupang T, Boer P, Mees EJ. Orv Hetil; 1981 Jun 21; 122(25):1519-27. PubMed ID: 7312332 [No Abstract] [Full Text] [Related]
40. [Description of a case of Bartter's syndrome: therapeutic considerations (author's transl)]. Ottolenghi A, Torti G, Fedeli F, Mussi G. Pediatr Med Chir; 1981 Jun 21; 3(4):315-8. PubMed ID: 7343924 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]